Inventiva S.A. (EPA:IVA)
France · Delayed Price · Currency is EUR 2.705
-0.030 (-1.10%)
Oct 19, 2026, 5:35 PM CET
Inventiva Market Cap
Inventiva has a market cap or net worth of €639.14 million as of October 19, 2026. It is the 12,116th most valuable company in the world and the 166th biggest in France. Its market cap has increased by 33.76% in one year.
Market Cap
639.14M
Enterprise Value
611.80M
Revenue
2.46M
Global Rank
Country Rank
#166 France
PE Ratio
n/a
ChartMarket Cap Chart
Since February 15, 2017, Inventiva's market cap has increased from 134.55M to 639.14M, an increase of 375.04%. That is a compound annual growth rate of 17.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 639.14M | -15.19% |
| Dec 31, 2025 | 753.62M | 261.37% |
| Dec 31, 2024 | 208.54M | -1.39% |
| Dec 29, 2023 | 211.49M | 12.21% |
| Dec 30, 2022 | 188.49M | -60.71% |
| Dec 31, 2021 | 479.69M | 6.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 971.51M |
| MedinCell | 923.65M |
| Valneva SE | 477.72M |
| DBV Technologies | 463.99M |
| Genfit | 420.26M |
| Valerio Therapeutics Société anonyme | 200.28M |
| Transgene | 188.43M |
| Innate Pharma | 122.00M |